industry private equity venture capital founded 2004 founder joshua kazam peter kash david tanen benjamin bernstein headquarters new york city new york key people arie belldegrun chairman 1 products venture capital equity investment investment management website www.tworiver.com two river group holdings is a new york based venture capital firm and merchant bank focused on the life science sector . it specializes in investments in life science biotechnology and in firms focused on developing preventative and therapeutic technologies for a broad spectrum of disease areas including oncology cardiovascular disease neurological disorders and companion animal health care . 2 two river was founded in september 2004 by partners joshua kazam 3 peter kash david tanen 4 and benjamin bernstein . 5 dr. arie belldegrun joined the firm in 2008 as chairman and partner . 6 the firm has offices in new york city and los angeles . contents 1 portfolio 2 recent business 3 references 4 external links portfolio edit two river has invested in the following life science companies 7 arno therapeutics otcbb arni arno is a clinical stage biopharmaceutical company that is developing innovative products for the treatment of cancer . capricor therapeutics formerly nile therapeutics otcbb capr capricor therapeutics inc. is a publicly traded heart failure biotechnology company is focused on the development of novel therapeutics to prevent and treat heart disease . cell design labs cell design labs is a private biotherapeutics company pioneering breakthrough science to develop disruptive cell based therapies for cancer and other devastating diseases . cell design labs leverages the power of the body s immune system to develop smart living therapies with the capability to treat our most challenging diseases with unprecedented power precision safety and durability . edgemont pharmaceuticals edgemont is a privately held pharmaceutical company with a primary focus and expertise in the field of neuroscience . edgemont is committed to the development of novel drug formulations and new therapies that can improve patient care . hubble kite pharma nasdaq kite kite pharma is a development stage biotechnology company engaged in the design and development of pioneering immune based targeted therapies to treat different cancer indications . kite has a portfolio of proprietary product candidates designed to stimulate the patient s own immune system to fight tumor cells . sienna sienna biopharmaceuticals sienna biopharmaceuticals is focused on the discovery clinical development and commercialization of products in dermatology and aesthetics based on scientific breakthroughs that dramatically improve patient outcomes and physicians practice of medicine . urogen pharma urogen pharma is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro oncology . velcera acquired by perrigo velcera develops pet medicines in pain management anti allergy and parasiticides that can provide superior convenience and greater compliance than traditional products . recent business edit in may 2013 kite pharma completed a 35 million financing of series a preferred stock . 8 in october 2013 arno therapeutics completed a 30.7 million financing of equity . 9 in november 2013 nile therapeutics completed a merger with capricor to form capricor therapeutics . capricor has become a wholly owned subsidiary of nile . 10 in february 2014 velcera was acquired by perrigo for 160 million . 11 in april 2014 kite pharma completed a 50 million mezzanine private financing of convertible notes 12 and in may the company filed a registration with the sec for an ipo of its common stock with a proposed maximum offering price of 115 million . the company listed on the nasdaq global market under the symbol kite . 13 14 the company planned to raise 78 million by offering 6 million shares at a price range of 12.00 to 14.00 . at the midpoint of the proposed range kite pharma would command a market value of 548 million . 15 16 on 20 june 2014 7.5 million shares of kite pharma priced at 17 a share began trading on the nasdaq indicating a market valuation of 632.4 million for the company . 17 18 references edit two river group holdings llc board committees . businessweek . retrieved 9 december 2013 . company overview of two river group holdings llc businessweek . retrieved on 26 june 2013 . joshua a. kazam businessweek . retrieved on 26 june 2013 . david m. tanen businessweek . retrieved on 26 june 2013 . benjamin bernstein businessweek . retrieved on 26 june 2013 . dr. arie s. belldegrun md facs joins two river group holdings as chairman and partner . reuters . 29 april 2008 . retrieved 26 june 2013 . portfolio two river . retrieved on 16 august 2016 . elliott peter 15 may 2013 . kite pharma completes 35 million series a preferred stock financing . istreetwire . retrieved 26 june 2013 . arno therapeutics completes 30.7 million financing recapitalization and 1 for 8 reverse stock split the wall street journal new york . 30 october 2013 . retrieved 31 october 2013 . capricor and nile therapeutics complete merger to form capricor therapeutics inc. . bloomberg . 21 november 2013 . retrieved 9 december 2013 . ail pallavi 1 february 2014 . perrigo expands further into pet care with velcera deal . reuters . retrieved 29 april 2014 . kite pharma inc. completes 50 million mezzanine private financing . marketwatch . 28 april 2014 . retrieved 29 april 2014 . kite pharma kite files 115m ipo . streetinsider . 19 may 2014 . retrieved 19 may 2014 . kite pharma files registration statement for proposed initial public offering . digital journal . 19 may 2014 . retrieved 19 may 2014 . dion don 18 june 2014 . ipo for kite pharma might fly high . seeking alpha . retrieved 18 june 2014 . 12 us ipos planned for the week of jun 16 . nasdaq . 16 june 2014 . retrieved 18 june 2014 . calia michael 20 june 2014 . kite pharma soars above ipo price on first day of trading . the wall street journal . retrieved 21 june 2014 . kite pharma kite ipo surges higher . streetinsider . 20 june 2014 . retrieved 21 june 2014 . external links edit two river official website two river on businessweek retrieved from https en.wikipedia.org w index.php title two river & oldid 738791405 categories companies established in 2004investment banking private equity groupsprivate equity firms of the united statescompanies based in new yorkventure capital firms of the united statesinvestment companies based in new york city navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages add links this page was last modified on 11 september 2016 at 02 35 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view